Table 2 Cox regression analysis of baseline hsCRP categories and hypertension status for predicting cardiovascular outcomes
Hazards ratio (95% CI) | |||
---|---|---|---|
Unadjusted model | Model 1 | Model 2 | |
All endpoint events | |||
HsCRP levels (Events/Subjects) | |||
<1 mg/La (162/1520) | 1.00 | 1.00 | 1.00 |
1–3 mg/L (218/1709) | 1.17 (0.95–1.43) | 1.16 (0.95–1.43) | 1.02(0.82–1.25) |
>3 mg/L (150/1062) | 1.30 (1.04–1.62)b | 1.29 (1.03–1.61)b | 1.14(0.90–1.43) |
Hypertension | 1.46 (1.21–1.76)c | 1.39 (1.15–1.68)c | 1.31 (1.08–1.60)c |
Hard endpoint events | |||
HsCRP levels (Events/Subjects) | |||
<1 mg/La (59/1520) | 1.00 | 1.00 | 1.00 |
1–3 mg/L (86/1709) | 1.23 (0.88–1.71) | 1.22 (0.88–1.70) | 1.00 (0.71–1.42) |
>3 mg/L (73/1062) | 1.71 (1.21–2.41)c | 1.68 (1.19–2.36)c | 1.40 (0.98–2.00) |
Hypertension | 1.65 (1.22–2.23)c | 1.50 (1.11–2.04)c | 1.47 (1.06–2.02)b |